Vanguard Group Inc Singular Genomics Systems, Inc. Transaction History

Vanguard Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.58 $6,435 - $11,311	-19,503 Reduced 1.03%	1,872,582 $861,000
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.28 $180,510 - $296,222	-231,424 Reduced 10.9%	1,892,085 $1.57 Million
Q1 2023 May 15, 2023	BUY	$1.1 - $2.95 $10,967 - $29,411	9,970 Added 0.47%	2,123,509 $2.57 Million
Q4 2022 Feb 10, 2023	BUY	$1.82 - $2.71 $431,090 - $641,898	236,863 Added 12.62%	2,113,539 $4.25 Million
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $422,355 - $799,095	-168,942 Reduced 8.26%	1,876,676 $4.69 Million
Q2 2022 Aug 12, 2022	BUY	$2.86 - $6.44 $1.58 Million - $3.56 Million	553,082 Added 37.06%	2,045,618 $7.81 Million
Q1 2022 May 13, 2022	SELL	$5.94 - $12.09 $4.37 Million - $8.9 Million	-736,424 Reduced 33.04%	1,492,536 $9.42 Million
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $13.5 Million - $21.9 Million	1,295,748 Added 138.85%	2,228,960 $25.8 Million
Q3 2021 Nov 12, 2021	BUY	$10.9 - $27.63 $1.93 Million - $4.9 Million	177,320 Added 23.46%	933,212 $10.4 Million
Q2 2021 Aug 13, 2021	BUY	$23.16 - $31.17 $17.5 Million - $23.6 Million	755,892 New	755,892 $20.8 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $960M
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.